JOCS

The aim of the Comprehensive Surgery is to publish original research articles of the highest scientific and clinical value at the international level in all surgical fields.

EndNote Style
Index
Case Report
Approach to anal sphincter dysfunctions in a patient with endorectal pull-through procedure
The seven-year-old male patient was examined in the pediatric surgery outpatient unit with abdominal distension. He had been operated on for congenital megacolon in the newborn period in another center. After a period of follow-up, he had been re-operated because of a diagnosis of insufficient pull-through, and a second pull-through had been performed. Following this procedure, myectomy and temporary colostomy procedures were reported in a different hospital. After all these treatments, he still had a distension episode, even associated with enterocolitis. In our clinic, we medically treated enterocolitis four times in 5 months. According to the council decision in our department, we decided to use a medically used botulin toxin (Botox) to evaluate a possible internal anal sphincter achalasia (IASA) and injected the Botox into the internal sphincter under anesthesia. Following the procedure, the patient was brought to our attention only once in 4 months with a mild distension. This data encouraged us to perform partial sphincteromy and internal sphincter myectomy. Nine months after the myectomy, the patient was not hospitalized and had a mild distension once. There is a significant improvement in his life quality; as a clear result, we observed and experienced that sphincter-related problems must be taken into account in incurable postoperative obstructive situations related to Hirschsprung's disease.


1. Svetanoff WJ, Lim-Beutal IIP, Wood RJ, Levitt MA, Rentea RM. The utilization of Botulinum toxin for Hirschsprung disease. Semin Pediatr Surg. 2022;31(2):151161. doi:10.1016/j.sempedsurg.2022.151161
2. Roorda D, Oosterlaan J, van Heurn E, Derikx J. Intrasphincteric Botulinum toxin injections for post-operative obstructive defecation problems in Hirschsprung disease: a retrospective observational study. J Pediatr Surg. 2021;56(8):1342-1348. doi:10.1016/j.jpedsurg.2020.11.025
3. Rice-Townsend SE, Nicassio L, Glazer D, et al. Characterizing the use of Botulinum toxin in patients with Hirschsprung disease treated at referral institutions for pediatric colorectal surgery. J Pediatr Surg. 2022; 57(6):1033-1039. doi:10.1016/j.jpedsurg.2022.02.005
4. Ahmad H, Rentea RM, Knaus ME, et al. Routine Botulinum toxin injection one month after a Swenson pull-through does not change the incidence of Hirschsprung associated enterocolitis. J Pediatr Surg. 2022; 57(8):1453-1457. doi:10.1016/j.jpedsurg.2021.11.029
5. Svetanoff WJ, Lopez J, Aguayo P, Hendrickson RJ, Oyetunji TA, Rentea RM. The impact of Botulinum injection for hospitalized children with Hirschsprung-associated enterocolitis. Pediatr Surg Int. 2021;37(10): 1467-1472. doi:10.1007/s00383-021-04966-3
6. Mohajerzadeh L, Zakeri AM, ZanganehKia M, Khaleghnejad Tabari A, Dara N. High dose botoxinjection for patients with internal anal sphincter achalasia persistent to posterior internal anal sphincter myectomy. Iranian J Pediatr Surg. 2020;6(2):66-73. doi:10.22037/irjps.v6i2.31946
7. Baaleman DF, Malamisura M, Benninga MA, et al. The not-so-rare absent RAIR: internal anal sphincter achalasia in a review of 1072 children with constipation undergoing high-resolution anorectal manometry. Neurogastroenterol Motil. 2021;33(4):e14028. doi:10.1111/nmo.14028
Volume 3, Issue 1, 2025
Page : 22-24
_Footer